These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 8493195)
1. Drug treatment of arthritis. Update on conventional and less conventional methods. Spencer-Green G Postgrad Med; 1993 May; 93(7):129-40. PubMed ID: 8493195 [TBL] [Abstract][Full Text] [Related]
2. Slow acting anti-rheumatic drugs in the treatment of rheumatoid arthritis. Kovarsky J Tex Med; 1985 Sep; 81(9):35-9. PubMed ID: 3931276 [No Abstract] [Full Text] [Related]
8. Drugs for rheumatoid arthritis. Med Lett Drugs Ther; 2000 Jul; 42(1082):57-64. PubMed ID: 10887424 [No Abstract] [Full Text] [Related]
9. Rheumatoid arthritis. Practical use of medications. Furst DE Postgrad Med; 1990 Feb; 87(3):79-92. PubMed ID: 2406713 [TBL] [Abstract][Full Text] [Related]
10. Current concepts in clinical therapeutics: disease-modifying drugs for rheumatoid arthritis. Pugh MC; Pugh CB Clin Pharm; 1987 Jun; 6(6):475-91. PubMed ID: 3319362 [TBL] [Abstract][Full Text] [Related]
11. DMARDs in the treatment of rheumatoid arthritis: current agents and future developments. Simon LS Int J Clin Pract; 2000 May; 54(4):243-9. PubMed ID: 10912314 [TBL] [Abstract][Full Text] [Related]
12. Safety of combination therapy with hydroxychloroquine, gold sodium thiomalate and methotrexate in early rheumatoid arthritis. Biasi D; Caramaschi P; Carletto A; Pacor ML; Bambara LM Rev Rhum Engl Ed; 1997; 64(7-9):521-2. PubMed ID: 9338941 [No Abstract] [Full Text] [Related]
14. Termination of slow acting antirheumatic therapy in rheumatoid arthritis: a 14-year prospective evaluation of 1017 consecutive starts. Wolfe F; Hawley DJ; Cathey MA J Rheumatol; 1990 Aug; 17(8):994-1002. PubMed ID: 1976811 [TBL] [Abstract][Full Text] [Related]
15. Role of disease-modifying antirheumatic drugs versus cytotoxic agents in the therapy of rheumatoid arthritis. Ward JR Am J Med; 1988 Oct; 85(4A):39-44. PubMed ID: 3052055 [TBL] [Abstract][Full Text] [Related]
16. Variability in individual responses of 532 patients with rheumatoid arthritis to first-line and second-line drugs. Pincus T; Callahan LF Agents Actions Suppl; 1993; 44():67-75. PubMed ID: 8103964 [TBL] [Abstract][Full Text] [Related]
17. The action of myocrisin on membrane bound sulphhydryl groups. McCrae F; Reglinski J; Smith WE; Brzeski M; Sturrock RD Clin Chim Acta; 1990 Dec; 195(1-2):41-5. PubMed ID: 1982710 [No Abstract] [Full Text] [Related]
18. Severe rheumatoid arthritis: current options in drug therapy. Kremer JM Geriatrics; 1990 Dec; 45(12):43-8. PubMed ID: 2123816 [TBL] [Abstract][Full Text] [Related]
19. Toxicity profiles of disease modifying antirheumatic drugs in rheumatoid arthritis. Singh G; Fries JF; Williams CA; Zatarain E; Spitz P; Bloch DA J Rheumatol; 1991 Feb; 18(2):188-94. PubMed ID: 1673721 [TBL] [Abstract][Full Text] [Related]
20. Current concepts regarding pharmacologic treatment of rheumatoid and osteoarthritis. Wildy KS; Wasko MC Hand Clin; 2001 May; 17(2):321-38, xi. PubMed ID: 11478054 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]